搜索临床试验以:序列 3 - 治疗 E:速释普瑞巴林
总计48个结果
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National... 和其他合作者完全的
-
Association Francaise pour la Recherche ThermaleUniversity Hospital, Grenoble; Floralis撤销
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Tulane UniversityNational Institute of General Medical Sciences (NIGMS)完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Yuhan Corporation完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Diurnal LimitedNational Institutes of Health Clinical Center (CC)完全的
-
Astellas Pharma Europe B.V.完全的
-
Brigham and Women's HospitalNational Institute on Drug Abuse (NIDA)主动,不招人
-
Milton S. Hershey Medical CenterChildren's Miracle Network终止
-
Jaime Moore, MD MPHNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Colorado-... 和其他合作者完全的
-
NRG OncologyNational Cancer Institute (NCI)撤销胶质母细胞瘤 | 间变性星形细胞瘤 | 少突神经胶质瘤 | 幕上胶质母细胞瘤
-
Janssen Research & Development, LLC完全的
-
National and Kapodistrian University of Athens终止
-
University of South DakotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Roswell Park Cancer Institute招聘中
-
Rabin Medical CenterTel Aviv University; The Leona M. and Harry B. Helmsley Charitable Trust招聘中
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
National Cancer Institute (NCI)招聘中